interleukin-1beta (163-171) has been researched along with aminoimidazole carboxamide in 1 studies
Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (aminoimidazole carboxamide) | Trials (aminoimidazole carboxamide) | Recent Studies (post-2010) (aminoimidazole carboxamide) |
---|---|---|---|---|---|
192 | 3 | 74 | 1,913 | 35 | 830 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ameur, A; Bergsten, P; Cen, J; Fred, RG; Kappe, C; Ravassard, P; Scharfmann, R; Welsh, N | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and aminoimidazole carboxamide
Article | Year |
---|---|
Role of the AMP kinase in cytokine-induced human EndoC-βH1 cell death.
Topics: Adenosine Triphosphate; Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Cell Death; Cell Line; Cell Respiration; Dactinomycin; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Interferon-gamma; Interleukin-1beta; Mice; Peptide Fragments; Ribonucleotides; Signal Transduction | 2015 |